PGRMC
1 (progesterone receptor membrane component 1), one of the progesterone receptor purified from porcine liver membranes in 1996, is widely seen in human kidney, liver, endometrium and ovary relatively strong expressed. Its functions which are metabolism and synthesis of steroid hormones and electrolyte have been elucidated in a variety cells including anti-apoptosis action in spontaneously immortalized granulosa cells. PGRMC
1 also has been seen in breast cancer cells, thyroid, colon, lung, ovarian cancer, especially in breast cancer the expression of PGRMC
1 was reported to have an association with prognosis, which indicates PGRMC
1 can have a role in tumorigenesis.
PGRMC
1 are also highly expressed in Ishikawa cell, human endometrial cancer cells, in which PI3K/AKT and MAPK pathway are over-expressed. PGRMC
1 knock-down showed to reduce the expression of PDK1 and phosphorylated-AKT on the PI3K/AKT signal pathway, but no effect on MAPK signaling.
Furthermore PGRMC
1 knock-down showed to induce apoptosis and, under hypoxic stress showed antitumor effects by suppressing the activity in Ishikawa cell.
Our works indicates that in endometrial cancer cell, PGRMC
1 can have a crosstalk with PI3K/AKT signal pathway through PDK1 and AKT to maintain the cell for survival.
The results suggest that the regulation of PGRMC
1 is critical for Ishikawa cells, therefore PGRMC
1 can be a one potential molecular target for the therapeutic treatment of endometrial cancer.
View full abstract